Arrowhead Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $3,551 | $16,097 |
Gross Profit | -4,782 | -4,525 | -712 | 12,238 |
EBITDA | -164,101 | -115,227 | -129,059 | -99,869 |
EBIT | -168,883 | -119,752 | -133,322 | -103,728 |
Net Income | -170,793 | -125,300 | -132,864 | -109,679 |
Net Change In Cash | 0 | 0 | 3,551 | 16,097 |
Free Cash Flow | -129,867 | -126,452 | -186,496 | -89,164 |
Cash | 69,399 | 127,704 | 58,215 | 110,891 |
Basic Shares | 124,199 | 123,285 | 107,415 | 107,312 |
Annual Financials
| Values in thousands | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
|---|---|---|---|---|
Revenue | $240,735 | $243,231 | $138,287 | $87,992 |
Gross Profit | 240,735 | 243,231 | 138,287 | 87,992 |
EBITDA | -175,672 | -168,086 | -132,580 | -87,217 |
EBIT | -188,165 | -178,507 | -140,846 | -93,159 |
Net Income | -205,275 | -176,494 | -140,848 | -84,553 |
Net Change In Cash | 240,735 | 243,231 | 138,287 | 87,992 |
Cost of Revenue | -76,362 | 40,851 | -78,221 | |
Free Cash Flow | -330,627 | -188,908 | 147,657 | -107,343 |
Cash | 110,891 | 108,005 | 184,434 | 143,582 |
Basic Shares | 106,750 | 105,426 | 103,745 | 100,722 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$1.38 |
2024-03-31 | -$1.02 |
2023-12-31 | -$1.24 |
2023-09-30 | -$1.02 |
